These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8904096)

  • 1. Significance of environmental conditions (pH and serum) on the in vitro potency of azithromycin against Brucella melitensis.
    Domingo S; Gastearena I; Diaz R; Gamazo C
    J Chemother; 1995 Nov; 7 Suppl 4():29-31. PubMed ID: 8904096
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of tigecycline and ertapenem against clinical isolates of Brucella melitensis detected by E-test on different media.
    Tanyel E; Coban AY; Fisgin NT; Tulek N
    Indian J Med Microbiol; 2010; 28(4):370-1. PubMed ID: 20966572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of azithromycin against Brucella melitensis.
    Qadri SM; Halim MA; Ueno Y; Abumustafa FM; Postle AG
    Chemotherapy; 1995; 41(4):253-6. PubMed ID: 7555205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.
    Orhan G; Bayram A; Zer Y; Balci I
    J Clin Microbiol; 2005 Jan; 43(1):140-3. PubMed ID: 15634962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
    Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
    Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Jenner DC; Sefton AM; MacMillan AP; Brooks TJ; Simpson AJ
    Int J Antimicrob Agents; 2010 Jul; 36(1):66-8. PubMed ID: 20022474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotypes and antimicrobial susceptibilities of Brucella isolates.
    Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
    Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs.
    Akova M; Gür D; Livermore DM; Kocagöz T; Akalin HE
    Antimicrob Agents Chemother; 1999 May; 43(5):1298-300. PubMed ID: 10223958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucellosis in a dog caused by Brucella melitensis Rev 1.
    Hinić V; Brodard I; Petridou E; Filioussis G; Contos V; Frey J; Abril C
    Vet Microbiol; 2010 Mar; 141(3-4):391-2. PubMed ID: 19828267
    [No Abstract]   [Full Text] [Related]  

  • 11. Tigecycline: its potential for treatment of brucellosis.
    Dizbay M; Kilic S; Hizel K; Arman D
    Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Elaboration of a rapid method of determining the sensitivity of Brucella to antibiotics].
    Zheludkov MM; Gubina EA; Lebedeva IK; D'iakov SI
    Antibiot Khimioter; 1992 May; 37(5):12-4. PubMed ID: 1417320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of fluoroquinolone resistance in Brucella melitensis.
    Ravanel N; Gestin B; Maurin M
    Int J Antimicrob Agents; 2009 Jul; 34(1):76-81. PubMed ID: 19261448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility data for Brucella melitensis isolates cultured from UK patients.
    Cooke RP; Perrett L
    J Infect; 2014 Apr; 68(4):401. PubMed ID: 24440739
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis.
    Gür D; Kocagöz S; Akova M; Unal S
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2337. PubMed ID: 10577353
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
    Maves RC; Castillo R; Guillen A; Espinosa B; Meza R; Espinoza N; Núñez G; Sánchez L; Chacaltana J; Cepeda D; González S; Hall ER
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1279-81. PubMed ID: 21199926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin.
    Koeth LM; Good CE; Saunders KA; Jakielaszek C
    Int J Antimicrob Agents; 2004 Aug; 24(2):144-9. PubMed ID: 15288313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antimicrobial susceptibility of Brucella species.
    Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
    Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antibiotics contained in two Brucella selective media on growth of Brucella abortus, B. melitensis, and B. ovis.
    Marín CM; Alabart JL; Blasco JM
    J Clin Microbiol; 1996 Feb; 34(2):426-8. PubMed ID: 8789029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
    Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
    Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.